益肾排毒方调控ROS/TXNIP/NLRP3通路对慢性肾衰竭大鼠肾纤维化的影响
x

请在关注微信后,向客服人员索取文件

篇名: 益肾排毒方调控ROS/TXNIP/NLRP3通路对慢性肾衰竭大鼠肾纤维化的影响
TITLE: Effects of Yishen paidu formula on renal fibrosis in rats with chronic renal failure by regulating the ROS/TXNIP/NLRP3 pathway
摘要: 目的 通过活性氧(ROS)/硫氧还蛋白相互作用蛋白(TXNIP)/NOD样受体热蛋白结构域相关蛋白3(NLRP3)通路,探讨益肾排毒方对慢性肾衰竭(CRF)大鼠肾纤维化的作用及机制。方法将大鼠随机分为对照组、模型组、益肾排毒方低剂量(益肾排毒方-L)组、益肾排毒方高剂量(益肾排毒方-H)组、益肾排毒方-H+携带阴性对照序列的pcDNA载体(pcDNA-NC)组、益肾排毒方-H+携带TXNIP基因的pcDNA载体(pcDNA-TXNIP)组,每组10只。除对照组外,其余大鼠均通过喂养含0.5%腺嘌呤的饲料构建CRF模型,并灌胃或尾静脉注射相应药物或生理盐水,每日1次,连续8周。末次给药后,检测各组大鼠血肌酐(Scr)、尿素氮(BUN)、活性氧(ROS)、超氧化物歧化酶(SOD)、丙二醛(MDA)、肿瘤坏死因子α(TNF-α)、白细胞介素(IL)-6、IL-1β水平;观察肾组织病理变化;检测肾组织中胶原蛋白Ⅲ(CollagenⅢ)、α-平滑肌肌动蛋白(α-SMA)、转化生长因子β(1TGF-β1)、TXNIP、NLRP3蛋白表达情况。结果与模型组比较,益肾排毒方-L组和益肾排毒方-H组大鼠肾组织病理损伤和纤维化均明显缓解,Scr、BUN、ROS、MDA、TNF-α、IL-6、IL-1β水平和CollagenⅢ、α-SMA、TGF-β1、TXNIP、NLRP3蛋白表达水平均明显/显著降低,SOD水平均显著升高(P<0.05),且益肾排毒方-H组变化更显著(P<0.05);与益肾排毒方-H+pcDNA-NC组比较,益肾排毒方-H+pcDNA-TXNIP组大鼠上述指标水平均显著逆转(P<0.05)。结论益肾排毒方可通过抑制ROS/TXNIP/NLRP3通路延缓CRF大鼠肾纤维化。
ABSTRACT: OBJECTIVE To investigate the effects and mechanism of the Yishen paidu formula on renal fibrosis in rats with chronic renal failure (CRF) through the reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP)/NOD-like receptor thermal protein domain associated protein 3 (NLRP3) pathway. METHODS Rats were randomly divided into control group, model group, Yishen paidu formula low-dose (Yishen paidu formula-L) group, Yishen paidu formula high-dose (Yishen paidu formula- H) group, Yishen paidu formula-H+pcDNA-NC group, and Yishen paidu formula-H+ pcDNA-TXNIP group, with 10 rats in each group. Except for control group, all other rats were fed a diet containing 0.5% adenine to establish a CRF model; the rats were then administered corresponding drugs or normal saline intragastrically or via tail vein, once daily, for 8 consecutive weeks. After the last administration, the levels of serum creatinine (Scr), blood urea nitrogen (BUN), ROS, superoxide dismutase (SOD), malondialdehyde (MDA), tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and IL-1β were measured in each group. Pathological changes in renal tissue were observed, and the protein expression levels of Collagen Ⅲ, α-smooth muscle actin (α-SMA), transforming growth factor-β1 (TGF-β1), TXNIP and NLRP3 in renal tissue were detected. RESULTS Compared with model group, the renal histopathological damage and fibrosis of rats in Yishen paidu formula-L group and Yishen paidu formula-H group were significantly alleviated. The levels of Scr, BUN, ROS, MDA, TNF- α, IL-6 and IL-1β, and the protein expressions of Collagen Ⅲ, α-SMA, TGF-β1, TXNIP and NLRP3 were significantly decreased, while SOD levels were significantly increased (P<0.05). Moreover, the changes were more pronounced in the Yishen paidu formula-H group (P<0.05). Compared with Yishen paidu formula-H+pcDNA-NC group, above indexes of rats in Yishen paidu formula-H+pcDNA-TXNIP group were reversed significantly (P<0.05). CONCLUSIONS Yishen paidu formula can inhibit renal fibrosis in CRF rats by suppressing the ROS/TXNIP/NLRP3 pathway.
期刊: 2026年第37卷第02期
作者: 冯立;彭博文;彭斌;冯雪;朱双益;熊玮;胡溪;孙小慧
AUTHORS: FENG Li,PENG Bowen,PENG Bin,FENG Xue,ZHU Shuangyi,XIONG Wei,HU Xi,SUN Xiaohui
关键字: 益肾排毒方;慢性肾衰竭;肾纤维化;ROS/TXNIP/NLRP3通路
KEYWORDS: Yishen paidu formula; chronic renal failure; renal fibrosis; ROS/TXNIP/NLRP3 pathway
阅读数: 3 次
本月下载数: 0 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!